BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 14.01 billion. The enterprise value is 14.22 billion.

Market Cap	14.01B
Enterprise Value	14.22B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 27.79% in one year.

Current Share Class	88.33M
Shares Outstanding	88.33M
Shares Change (YoY)	+27.79%
Shares Change (QoQ)	+12.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.59%
Float	25.00M

Valuation Ratios

The trailing PE ratio is 28.71.

PE Ratio	28.71
Forward PE	n/a
PS Ratio	2.40
PB Ratio	3.01
P/TBV Ratio	3.01
P/FCF Ratio	n/a
P/OCF Ratio	46.74
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.35, with an EV/FCF ratio of -478.80.

EV / Earnings	31.81
EV / Sales	2.44
EV / EBITDA	15.35
EV / EBIT	19.37
EV / FCF	-478.80

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.37.

Current Ratio	2.36
Quick Ratio	1.07
Debt / Equity	0.37
Debt / EBITDA	1.86
Debt / FCF	-58.05
Interest Coverage	6.37

Financial Efficiency

Return on equity (ROE) is 12.74% and return on invested capital (ROIC) is 8.38%.

Return on Equity (ROE)	12.74%
Return on Assets (ROA)	6.55%
Return on Invested Capital (ROIC)	8.38%
Return on Capital Employed (ROCE)	11.24%
Revenue Per Employee	10.91M
Profits Per Employee	835,789
Employee Count	535
Asset Turnover	0.83
Inventory Turnover	2.70

Taxes

In the past 12 months, BF Biosciences has paid 276.59 million in taxes.

Income Tax	276.59M
Effective Tax Rate	38.22%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	164.44
200-Day Moving Average	174.83
Relative Strength Index (RSI)	49.33
Average Volume (20 Days)	779,997

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 5.84 billion and earned 447.15 million in profits. Earnings per share was 5.52.

Revenue	5.84B
Gross Profit	2.28B
Operating Income	734.56M
Pretax Income	723.74M
Net Income	447.15M
EBITDA	926.49M
EBIT	734.56M
Earnings Per Share (EPS)	5.52

Balance Sheet

The company has 1.51 billion in cash and 1.72 billion in debt, giving a net cash position of -213.54 million or -2.42 per share.

Cash & Cash Equivalents	1.51B
Total Debt	1.72B
Net Cash	-213.54M
Net Cash Per Share	-2.42
Equity (Book Value)	4.66B
Book Value Per Share	52.78
Working Capital	2.21B

Cash Flow

In the last 12 months, operating cash flow was 299.79 million and capital expenditures -329.49 million, giving a free cash flow of -29.71 million.

Operating Cash Flow	299.79M
Capital Expenditures	-329.49M
Free Cash Flow	-29.71M
FCF Per Share	-0.34

Margins

Gross margin is 39.14%, with operating and profit margins of 12.58% and 7.66%.

Gross Margin	39.14%
Operating Margin	12.58%
Pretax Margin	12.40%
Profit Margin	7.66%
EBITDA Margin	15.87%
EBIT Margin	12.58%
FCF Margin	n/a

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.79%
Shareholder Yield	-27.79%
Earnings Yield	3.19%
FCF Yield	-0.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BF Biosciences has an Altman Z-Score of 4.43 and a Piotroski F-Score of 6.

Altman Z-Score	4.43
Piotroski F-Score	6